Clearside Royalty LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Feb 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Ocular Injection Kit, Packaging, and Methods of Use (US 10,390,901) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due May 10, 2027The maintenance fee for Apparatus and Methods for Ocular Injection (US 9,180,047) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 1 fee due Jun 30, 2027The maintenance fee for Apparatus and Methods for Ocular Injection (US 10,517,756) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Apparatus and Methods for Ocular Injection (US 10,555,833) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D750,223 | Medical Injector for Ocular Injection In force · High confidence | In force | High confidence | |
| US 9,572,800 | Methods and Devices for the Treatment of Ocular Diseases in Human Subjects In force · High confidence | In force | High confidence | |
| US 9,636,332 | Methods and Devices for the Treatment of Ocular Diseases in Human Subjects In force · Medium confidence | In force | Medium confidence | |
| US 9,931,330 | Methods and Devices for the Treatment of Ocular Diseases in Human Subjects In force · Medium confidence | In force | Medium confidence | |
| US 9,180,047 | Apparatus and Methods for Ocular Injection In force · High confidence | In force | High confidence | |
| US 9,636,253 | Apparatus and Methods for Ocular Injection In force · High confidence | In force | High confidence | |
| US 9,770,361 | Apparatus and methods for ocular injection In force · From the USPTO record | In force | From the USPTO record | |
| US 9,937,075 | Apparatus and Methods for Ocular Injection In force · Medium confidence | In force | Medium confidence | |
| US 10,517,756 | Apparatus and Methods for Ocular Injection In force · Low confidence | In force | Low confidence | |
| US 10,555,833 | Apparatus and Methods for Ocular Injection In force · Low confidence | In force | Low confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.